Evidence map›Paper›PMID 33411619›Full record

ArticleJCO clinical cancer informatics2021

Chemotherapy Knowledge Base Management in the Era of Precision Oncology.

Samuel M Rubinstein, Tarsheen Sethi, Neeta K Venepalli, Bishal Gyawali, Candice Schwartz, Donna R Rivera, Peter C Yang, Jeremy L Warner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO clinical cancer informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samuel M RubinsteinUniversity of North Carolina at Chapel Hill, Chapel Hill, NC.
Tarsheen SethiYale University, New Haven, CT.
Neeta K VenepalliUniversity of Illinois at Chicago College of Medicine, Chicago, IL.
Bishal GyawaliQueens University, Kingston, Ontario, Canada.
Candice SchwartzUniversity of Illinois at Chicago College of Medicine, Chicago, IL.
Donna R RiveraDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Peter C YangDivision of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Jeremy L WarnerVanderbilt University Medical Center, Nashville, TN.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Network Analysis for a Data-Driven Approach to Cancer CareU01CA231840 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARNER, JEREMY LYLE · 2018 to 2020
$1.2M
NCATS NIH HHS UL1 TR001863NCI NIH HHS U01 CA231840
6 · The paper itself

Abstract

Cancer medicine has grown increasingly complex in recent years with the advent of precision oncology and wide utilization of multidrug regimens. Representing this increasingly granular knowledge is a significant challenge. As users and managers of a freely available chemotherapy drug and regimen database, we describe the changes we have made to accommodate these challenges. These include the development of a domain ontology and increased granularity in the classification of cancer types on the website.

Indexed as

Antineoplastic AgentsKnowledge BasesNeoplasmsHumansMedical OncologyPrecision MedicineAntineoplastic Agents

Identifiers

PMID33411619
PMCPMC8189622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.